IHC Market growth is largely driven by the rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests. However, the high degree of consolidation in the by the major market players is expected to restrain the growth of this market during the forecast period.
According to the new market research report Immunohistochemistry Market
by Product (Antibodies, Reagents, Equipment, Kits), Application
(Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research,
Forensic), End user (Hospitals, Diangostic labs, Academia) - Global
Forecast to 2026, published by MarketsandMarkets™, the global IHC Market
is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in
2021, at a CAGR of 7.7% during the forecast period.
Browse in-depth TOC on "Immunohistochemistry Market"
342 – Tables
48 – Figures
352 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121632939
The
Kits product segment accounted for the highest growth rate in the
immunohistochemistry market, by product, during the forecast period.
In
2020, the Kits product segment accounted for the share of around 12% of
the immunohistochemsitry market. The demand for complete solutions from
a single provider, like closed-system reagents with calibrated
measurements of the required quantity of reagents and controls among
diagnostic laboratories, hospitals, research institutes, and other end
users, is growing. Moreover, ready-to-use kits simplify the IHC process
by rectifying the initial time-consuming selections of primary
antibodies and appropriate stains. This is fueling the growth of the
immunohistochemistry kits market.
Diagnostic applications segment accounted for the largest share of the application segment.
Based
on application, the IHC market is segmented into diagnostic, research,
and forensic applications. The Diagnostic application segment dominated
this market in 2020 and is estimated to register the highest growth
during the forecast period. The growth of this segment is majorly
attributed to factors such as the advantages of IHC over traditionally
used special enzyme staining techniques that identify only a limited
number of proteins, enzymes, and tissue structures. Therefore, IHC has
become a crucial technique and is widely used for medical research as
well as clinical diagnostics.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121632939
Hospitals & Diagnostic Laboratories segment accounted for the largest share of the end user segment.
Based
on end user, the IHC market is segmented into hospitals &
diagnostic laboratories, academic & research institutes, and other
end users. The hospitals & diagnostic laboratories segment accounted
for the largest share (74.8%) of the market in 2020. The increasing
number of specialty diagnostic tests performed in hospital laboratories,
the rising number of in-house diagnostic procedures in hospitals, and
the increasing trend of establishing in-house diagnostic capabilities in
hospitals to provide time-bound and affordable patient services are
factors driving the growth of this market segment.
Asia Pacific: The fastest-growing region in the immunohistochemistry market.
Based
on the region, the immunohistochemistry market is broadly segmented
into North America, Europe, Asia-Pacific and Rest of the World. APAC is
expected to register the fastest growth rate during the forecast period
owing to several factors, including increasing disposable income, rising
healthcare spending, growing demand for quality medical care, and
increasing investments by pharmaceutical and biopharmaceutical
companies. The rising prevalence of chronic ailments, rapidly increasing
geriatric population, growing academic and government investments in
diagnostic research, and the presence of many market players are the
other major factors driving the growth of the ihc market in APAC.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121632939
Prominent
players operating in the global immunohistochemistry market include F.
Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent
Technologies, Inc. (US).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com